SCHEMBL101223

SCHEMBL101223

O=C(O)Nc1cc(CCCC(=O)Nc2ccc(CO)cc2)ccc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.51
HDAC2 Q92769 6/20 0.51
HDAC3 O15379 5/20 0.51
HDAC4 P56524 5/20 0.51
HDAC7 Q8WUI4 5/20 0.51
HDAC10 Q969S8 5/20 0.51
HDAC11 Q96DB2 5/20 0.51
HDAC8 Q9BY41 5/20 0.51
HDAC6 Q9UBN7 5/20 0.51
HDAC9 Q9UKV0 5/20 0.51
HDAC5 Q9UQL6 5/20 0.51
TRPV1 Q8NER1 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
KDM1A O60341 2/20 0.50
MEN1 O00255 1/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
MAPKAPK2 P49137 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL101623 0.97 HDAC2 (0.48) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL98704 0.93 AKR1C3 (0.51) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL99035 0.91 HDAC1 (0.51) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL99412 0.90 HCAR2 (0.47) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL15822177 0.89 HDAC1 (0.47) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL15823927 0.88 ALDH1A1 (0.45) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL101227 0.87 NPC1 (0.45) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL15822069 0.86 HDAC1 (0.44) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL100635 0.85 MEN1 (0.48) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL102437 0.85 RORC (0.48) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426121-A1 QUATERNARY AMMONIUM SALT COMPOUND Teijin Pharma Limited (JP) 2012-03-07 EP claimed
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed